Congratulations @NoubarAfeyan of @FlagshipPioneer, on receiving the Committee for Economic Development’s Annual Distinguished Leadership Award that recognizes business leaders who have demonstrated exceptional leadership in very challenging times. We’re proud to support you.
We've launched #GOODDirectors, a first-of-its-kind national program designed to create opportunities for next-generation, #BIPOC, #LGBTQ+ and women leaders to join Boards of Directors of public companies. Read more now at the link: https://t.co/0llTnx1dkp #boarddiversity#DEI
Today, on its 2nd Annual Vaccines Day, we celebrate
@moderna_tx's #COVID19 vaccine which is now protecting millions of lives around the globe – & giving a world that’s been shut down hope for a brave new reopening. Explore Moderna’s incredible journey: https://t.co/eH1d8lhV6f
It was my pleasure to host @NoubarAfeyan, Chairman & Co-Founder of @Moderna at our 2nd Annual Goodwin + @KPMG@jpmorgan Symposium for a conversation about Board governance at #Moderna, his role as Chairman, & challenges he encountered over the past year: https://t.co/e6QGLK3XLn
We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study.
Read more: https://t.co/vYWEy8CKCv
Congratulations to @moderna_tx's Said Francis and @goodwinlaw's Sarah Solomon and the full Goodwin team for their work in representing Moderna on the 50 million dose order from Takeda/Japan announced this morning. Go Moderna Go!
Tune in this Wednesday, July 1 as my #GoodwinLaw colleagues and I engage in a lively and practical discussion of take-private transactions, and their potential role in the economic recovery. RSVP at the link: https://t.co/goSxaLYyUU
We just announced an award from U.S. government agency @BARDA for up to $483 million to accelerate development of our mRNA vaccine (mRNA-1273) against novel coronavirus https://t.co/Sn20aJVr8Z